Overview

Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine

Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The objective of this randomized, double blind study is to demonstrate that one dose oral "excedrin migraine" (acetaminophen, aspirin and caffeine) is not inferior when compared to one dose of intravenous prochlorperazine for the treatment of acute migraine headaches in the emergency department.
Phase:
Phase 4
Details
Lead Sponsor:
Albert Einstein Healthcare Network
Treatments:
Acetaminophen
Aspirin
Caffeine
Prochlorperazine